BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34704370)

  • 1. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
    Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
    Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational study.
    Chollet B; Guinde J; Laroumagne S; Dutau H; Astoul P
    Thorac Cancer; 2021 Jun; 12(11):1752-1756. PubMed ID: 33949775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
    Abisheganaden J; Verma A; Dagaonkar RS; Light RW
    Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.
    Asciak R; Kanellakis NI; Bibby A; Kidd A; Gerry S; Mercer R; Maskell N; Blyth KG; Fsadni P; Montefort S; Psallidas I; Rahman NM
    Chest; 2021 Nov; 160(5):1925-1933. PubMed ID: 34119515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of the LENT score in patients with malignant pleural mesothelioma.
    Söyler Y; Kavurgacı S; Gürel Akan E; Yılmaz Ü
    Tuberk Toraks; 2022 Dec; 70(4):341-348. PubMed ID: 36537091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
    Zauderer MG; Martin A; Egger J; Rizvi H; Offin M; Rimner A; Adusumilli PS; Rusch VW; Kris MG; Sauter JL; Ladanyi M; Shen R
    Lancet Digit Health; 2021 Sep; 3(9):e565-e576. PubMed ID: 34332931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
    Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
    Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
    Harris EJA; Kao S; McCaughan B; Nakano T; Kondo N; Hyland R; Nowak AK; de Klerk NH; Brims FJH
    J Thorac Oncol; 2019 Feb; 14(2):288-293. PubMed ID: 30366103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
    Fontana V; Pistillo MP; Vigani A; Canessa PA; Berisso G; Giannoni U; Ferro P; Franceschini MC; Carosio R; Tonarelli M; Rossi C; Dessanti P; Roncella S
    Anticancer Res; 2019 Sep; 39(9):5219-5223. PubMed ID: 31519636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prognostication scores and proposal for refinement in malignant pleural effusion in Asians.
    Wong C; Wing-Cheuk Wong R; Kit-Ying So L; Yin-Chun Yam L
    Respir Med; 2021; 189():106650. PubMed ID: 34688123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.
    Bibby AC; Clive AO; Slade GC; Morley AJ; Fallon J; Psallidas I; Pepperell JCT; Slade MG; Stanton AE; Rahman NM; Maskell NA
    Chest; 2015 Jul; 148(1):235-241. PubMed ID: 25429399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
    Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
    BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
    Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
    Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study.
    Saracino L; Bortolotto C; Tomaselli S; Fraolini E; Bosio M; Accordino G; Agustoni F; Abbott DM; Pozzi E; Eleftheriou D; Morbini P; Rinaldi P; Primiceri C; Lancia A; Comoli P; Filippi AR; Stella GM
    BMC Cancer; 2021 Jul; 21(1):762. PubMed ID: 34210265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
    Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B
    Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.
    Dozin B; Carbotti G; Roncella S; Ferro P; Dessanti P; Canessa PA; Ferrini S; Fabbi M
    Cancer Immunol Immunother; 2021 Nov; 70(11):3349-3355. PubMed ID: 34003301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses.
    Paajanen J; Laaksonen S; Ilonen I; Vehmas T; Mäyränpää MI; Sutinen E; Kettunen E; Salo JA; Räsänen J; Wolff H; Myllärniemi M
    Clin Lung Cancer; 2020 Nov; 21(6):e633-e639. PubMed ID: 32624414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
    Foo CT; Paterson A; Duckworth A; Herre J
    Chest; 2021 Dec; 160(6):e609-e611. PubMed ID: 34872672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with malignant pleural effusion undergoing talc pleurodesis.
    Hassan M; Mercer RM; Maskell NA; Asciak R; McCracken DJ; Bedawi EO; Shaarawy H; El-Ganady A; Psallidas I; Miller RF; Rahman NM
    Lung Cancer; 2019 Nov; 137():14-18. PubMed ID: 31521977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma.
    Fortin M; Cabon E; Berbis J; Laroumagne S; Guinde J; Elharrar X; Dutau H; Astoul P
    Respiration; 2020; 99(1):28-34. PubMed ID: 31655816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.